Table 3 Blood test results.
From: Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management
Test (mmol/L) | Baseline | Follow-up | ||
|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean difference (SD) | p | |
Hb | 142 (± 11.1) | 141 (± 10.9) | − 1.14 (± 7.20) | 0.268 |
Leukocytes | 6.49 (± 1.36) | 7.12 (± 1.66) | + 0.63 (± 1.16) | 0.00034 |
Thrombocytes | 220 (± 50.2) | 218 (± 44.2) | − 2.42 (± 26.9) | 0.528 |
Eosinophils | 0.26 (± 0.18) | 0.29 (± 0.30) | + 0.03 (± 0.25) | 0.359 |
Basophils | 0.05 (± 0.03) | 0.07 (± 0.03) | + 0.01 (± 0.03) | 0.008 |
Monocytes | 0.61 (± 0.19) | 0.66 (± 0.18) | + 0.06 (± 0.14) | 0.008 |
Neutrophils | 3.83 (± 1.02) | 4.43 (± 1.42) | + 0.61 (± 1.01) | 0.0001 |
Lymphocytes | 2.03 (± 0.47) | 2.05 (± 0.51) | + 0.02 (± 0.34) | 0.680 |
Neutrophil:lymphocyte ratio | 1.95 (± 0.61) | 2.29 (± 0.92) | + 0.34 (± 0.71) | 0.001 |
Cholesterol, total | 4.14 (± 1.13) | 3.79 (± 1.05) | − 0.35 (± 0.72) | 0.001 |
Triglycerides | 1.25 (± 0.50) | 1.21 (± 0.57) | − 0.038 (± 0.36) | 0.455 |
HDL | 1.41 (± 0.46) | 1.35 (± 0.46) | − 0.07 (± 0.23) | 0.050 |
LDL | 2.16 (± 0.96) | 1.88 (± 0.83) | − 0.28 (± 0.56) | 0.001 |
NONHDL | 2.71 (± 1.09) | 2.43 (± 1.00) | − 0.28 (± 0.63) | 0.003 |
ApolipoproteinA1 | 1.49 (± 0.31) | 1.48 (± 0.32) | − 0.01 (± 0.19) | 0.782 |
ApolipoproteinB1 | 0.84 (± 0.26) | 0.78 (± 0.27) | − 0.06 (± 0.16) | 0.008 |
ApoB/ApoA | 0.61 (± 0.25) | 0.54 (± 0.21) | − 0.07 (± 0.16) | 0.004 |
hsCRP (median [iq range]) | 1.5 (2.5) | 1.3 (2.8) | − 0.15 (1.02) | 0.447 |
HbA1c | 43.2 (± 13.0) | 41.1 (± 10.5) | − 2.11 (± 10.8) | 0.174 |
f-Glucose | 6.22 (± 1.45) | 6.70 (± 4.19) | + 0.48 (± 4.29) | 0.498 |
